Clinical Trials · NCT02059213
A Phase II Study of Androgen Deprivation Therapy With or Without Palbociclib in RB-Positive Metastatic Prostate Cancer
- Phase
- Phase 2
- Recruitment status
- Completed
- Sponsor
- University of Michigan Rogel Cancer Center
- Enrollment
- 72
- Start date
- Jun 2014
- Locations
- 8 sites, United States
- Primary endpoint
- Number of Patients Who Achieve a PSA ≤ 4ng/mL After Seven Months of Protocol Treatment in Each Arm